MIAMI, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) — Veru Inc. VERU, a late clinical stage biopharmaceutical company focused on developing novel medicines for breast cancer and for viral acute respiratory distress syndrome (ARDS), today announced it will host a conference call and audio webcast on Thursday, August 10, 2023, at…Read More
Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10 2023 Veru NASDAQVERU
